Cargando…
High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma
Different subtypes of non-small cell lung cancer (NSCLC) have distinct sites of origin, histologies, genetic and epigenetic changes. In this study, we explored the mechanisms of ECT2 dysregulation and compared its prognostic value in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC)...
Autores principales: | Zhou, Shijie, Wang, Ping, Su, Xiaolan, Chen, Jingxia, Chen, Hongfen, Yang, Hanbing, Fang, Aiping, Xie, Linshen, Yao, Yuqin, Yang, Jinliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663495/ https://www.ncbi.nlm.nih.gov/pubmed/29088286 http://dx.doi.org/10.1371/journal.pone.0187356 |
Ejemplares similares
-
Correction: High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma
por: Zhou, Shijie, et al.
Publicado: (2018) -
CGB5 expression is independently associated with poor overall survival and recurrence‐free survival in patients with advanced gastric cancer
por: Yang, Yuxin, et al.
Publicado: (2018) -
Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma
por: Liu, Xi, et al.
Publicado: (2018) -
Low CFB expression is independently associated with poor overall and disease-free survival in patients with lung adenocarcinoma
por: He, Chenglu, et al.
Publicado: (2021) -
Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma
por: Su, Xiaolan, et al.
Publicado: (2019)